These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 10760769

  • 1. Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis.
    Machens A, Gimm O, Ukkat J, Hinze R, Schneyer U, Dralle H.
    Cancer; 2000 Apr 15; 88(8):1909-15. PubMed ID: 10760769
    [Abstract] [Full Text] [Related]

  • 2. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas.
    Weber T, Schilling T, Frank-Raue K, Colombo-Benkmann M, Hinz U, Ziegler R, Klar E.
    Surgery; 2001 Dec 15; 130(6):1044-9. PubMed ID: 11742336
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Lymph node involvement and prognosis in medullary cancers of the thyroid gland].
    Mathonnet M, Cubertafond P, Teissier MP, Boutros-Toni F, Gainant A.
    Chirurgie; 2001 Dec 15; 120(12):117-22. PubMed ID: 8746014
    [Abstract] [Full Text] [Related]

  • 5. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
    Mirallié E, Iacobone M, Sebag F, Henry JF.
    Eur J Surg Oncol; 2004 Sep 15; 30(7):790-5. PubMed ID: 15296996
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Skip metastases in thyroid cancer leaping the central lymph node compartment.
    Machens A, Holzhausen HJ, Dralle H.
    Arch Surg; 2004 Jan 15; 139(1):43-5. PubMed ID: 14718274
    [Abstract] [Full Text] [Related]

  • 9. [The concept of "microsurgical" technique in medullary thyroid carcinoma].
    Mann B, Buhr HJ, Faulhaber J.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Jan 15; 115():720-3. PubMed ID: 9931710
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
    Leggett MD, Chen SL, Schneider PD, Martinez SR.
    Ann Surg Oncol; 2008 Sep 15; 15(9):2493-9. PubMed ID: 18594930
    [Abstract] [Full Text] [Related]

  • 11. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
    Machens A, Lorenz K, Dralle H.
    Ann Surg; 2009 Aug 15; 250(2):305-10. PubMed ID: 19638924
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma.
    Machens A, Holzhausen HJ, Lautenschläger C, Thanh PN, Dralle H.
    Cancer; 2003 Aug 15; 98(4):712-9. PubMed ID: 12910514
    [Abstract] [Full Text] [Related]

  • 13. Prediction of lateral lymph node metastases in medullary thyroid cancer.
    Machens A, Hauptmann S, Dralle H.
    Br J Surg; 2008 May 15; 95(5):586-91. PubMed ID: 18300267
    [Abstract] [Full Text] [Related]

  • 14. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
    Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, Schlumberger M.
    J Clin Endocrinol Metab; 2003 May 15; 88(5):2070-5. PubMed ID: 12727956
    [Abstract] [Full Text] [Related]

  • 15. Medullary thyroid microcarcinoma recommendations for treatment - a single-center experience.
    Scheuba C, Kaserer K, Bieglmayer C, Asari R, Riss P, Drosten R, Niederle B.
    Surgery; 2007 Dec 15; 142(6):1003-10; discussion 1010.e1-3. PubMed ID: 18063088
    [Abstract] [Full Text] [Related]

  • 16. Persistent hypercalcitoninemia in patients with medullary thyroid cancer: a therapeutic approach based on selective venous sampling for calcitonin.
    Medina-Franco H, Herrera MF, López G, Tielve-Campillo M, Sierra M, Lozano-Salazar RR, González O.
    Rev Invest Clin; 2001 Dec 15; 53(3):212-7. PubMed ID: 11496707
    [Abstract] [Full Text] [Related]

  • 17. Neck management in medullary thyroid carcinoma.
    Oskam IM, Hoebers F, Balm AJ, van Coevorden F, Bais EM, Hart AM, van den Brekel MW.
    Eur J Surg Oncol; 2008 Jan 15; 34(1):71-6. PubMed ID: 17555910
    [Abstract] [Full Text] [Related]

  • 18. Radioactive iodine treatment in medullary thyroid carcinoma.
    Faik Erdogan M, Gursoy A, Erdogan G, Kamel N.
    Nucl Med Commun; 2006 Apr 15; 27(4):359-62. PubMed ID: 16531922
    [Abstract] [Full Text] [Related]

  • 19. Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
    Machens A, Dralle H.
    J Clin Endocrinol Metab; 2010 Jun 15; 95(6):2655-63. PubMed ID: 20339026
    [Abstract] [Full Text] [Related]

  • 20. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
    Pelizzo MR, Boschin IM, Bernante P, Toniato A, Piotto A, Pagetta C, Nibale O, Rampin L, Muzzio PC, Rubello D.
    Eur J Surg Oncol; 2007 May 15; 33(4):493-7. PubMed ID: 17125960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.